Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MagDI Italian Study

NCT: NCT06613711 · COMPLETED

NCT IDNCT06613711
StatusCOMPLETED
Start Date2024-09-20
Completion2026-02-24

Brief Summary

The objective of the MagDI Italy Study is to evaluate the feasibility / performance, safety, and initial efficacy of the MagDI System in eligible participants who are indicated for a duodeno-ileal (small bowel) side-to-side anastomosis procedure for partial intestinal diversion (e.g., one example of a small bowel clinical procedure requiring a side-to-side anastomosis).

Frequently Asked Questions

What is MagDI Italian Study?

MagDI Italian Study is a clinical trial registered under NCT06613711. Current status: COMPLETED.

What is the status of NCT06613711?

The current status of NCT06613711 (MagDI Italian Study) is: COMPLETED.

When did MagDI Italian Study start?

MagDI Italian Study started on 2024-09-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.